Starpharma Holdings Ltd Cash Flow Reinvestment Rate
Latest as of December 2025:
0.06x
Starpharma Holdings Ltd cash flow reinvestment rate. Starpharma Holdings Ltd (SPL) has a Cash Flow Reinvestment Rate of 0.06x as of December 2025, reinvesting AU$237.00K (capex AU$237.00K ) from operating cash flow of AU$3.91 Million. Explore Starpharma Holdings Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.06x
(Capex + Investments) / Operating CF
Total Reinvested
AU$237.00K
Capex + Investments
Operating Cash Flow
AU$3.91 Million
AUD
Capital Expenditures
AU$237.00K
AUD
Starpharma Holdings Ltd Cash Flow Reinvestment Rate by Year (None–None)
Starpharma Holdings Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Starpharma Holdings Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Starpharma Holdings Ltd.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow